{"meta":{"query_hash":"c68c762d5bf5","filters":{"venue":"Journal of Managed Care Pharmacy"},"cohort_total":34,"direct_labels_cover":0,"predictions_cover":34,"exported":34,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c68c762d5bf5","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Managed+Care+Pharmacy"},"results":[{"id":"W2096831111","doi":"10.18553/jmcp.2005.11.3.211","title":"Effect of Prescriber Education on the Use of Medications Contraindicated in Older Adults in a Managed Medicare Population","year":2005,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Medicare Part D; Medical prescription; Managed care; Population; Prescription drug; Medicare Advantage; Medication therapy management; Pharmacist; Incidence (geometry); Quarter (Canadian coin); Family medicine; Emergency medicine; Health care; Nursing","score_opus":0.06944851455571585,"score_gpt":0.41027713473778743,"score_spread":0.3408286201820716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096831111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970594,0.00050288835,0.000046670742,0.0006803138,0.000015599262,0.00005670457,0.0001859548,0.000012386475,0.0014400498],"genre_scores_gemma":[0.9989015,0.0001952822,0.0001319916,0.0002858699,0.00004688275,0.000033431665,0.0001429965,0.0000014985876,0.00026056942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996995,0.0016484266,0.00022585328,0.00023988615,0.0005734114,0.00031749246],"domain_scores_gemma":[0.9837367,0.006419566,0.00657366,0.00041952744,0.0006939977,0.002156451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030086837,0.0002545869,0.00032205155,0.00050232233,0.00035958286,0.00048132797,0.00043561895,0.0009189734,0.0023856924],"category_scores_gemma":[0.025244888,0.00016178674,0.00069395883,0.00035275644,0.00026487146,0.0005803859,0.00062462414,0.00081699574,0.0002219393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021802546,0.004773199,0.95568246,0.00008674584,0.0003071043,0.000047053672,0.00017929761,0.00035569468,0.00017413158,0.000037779642,0.0007253341,0.035450842],"study_design_scores_gemma":[0.00007774473,0.0017639523,0.9974496,0.000016969328,0.00006650176,0.00002657825,0.000051813804,0.00024924288,0.00008544795,0.000011702322,0.0001974349,0.0000029696744],"about_ca_topic_score_codex":0.011638758,"about_ca_topic_score_gemma":0.010253783,"teacher_disagreement_score":0.011638758,"about_ca_system_score_codex":0.00089628145,"about_ca_system_score_gemma":0.0010081539,"threshold_uncertainty_score":0.02314204},"labels":[],"label_agreement":null},{"id":"W2101212412","doi":"10.18553/jmcp.2009.15.6.476","title":"Retrospective Observational Assessment of Statin Adherence Among Subjects Patronizing Different Types of Community Pharmacies in Canada","year":2009,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"Fondation pour la Recherche Médicale","keywords":"Medicine; Medical prescription; Pharmacy; Statin; Family medicine; Observational study; Retrospective cohort study; Prescription drug; Emergency medicine; Internal medicine; Pharmacology","score_opus":0.08833362095337416,"score_gpt":0.37750319978693053,"score_spread":0.2891695788335564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101212412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364823,0.0002621009,0.000104784835,0.00005430264,0.000004340204,0.00011577571,0.004999646,0.000008558347,0.00080212246],"genre_scores_gemma":[0.9962896,0.00023669623,0.0002198671,0.000076987424,0.00000384123,0.000050181116,0.0026553862,0.0000034521931,0.00046399792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985185,0.00011014037,0.00013635353,0.0002714746,0.00054439605,0.0004190402],"domain_scores_gemma":[0.9961785,0.00015476727,0.00089273474,0.00012677838,0.0018351763,0.0008119408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007570941,0.00048945105,0.0006040043,0.0023583432,0.0023573718,0.001260825,0.0013548306,0.0005469512,0.0011866903],"category_scores_gemma":[0.0020273158,0.000577075,0.00056372635,0.0069625983,0.00066118466,0.00040640397,0.0010267058,0.0007651402,0.0002914098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005491145,0.000024738234,0.99840873,0.000013543081,0.000026779115,0.000039388207,0.00019777747,0.000028930974,0.00009245983,0.000010267036,0.00017623724,0.0009261855],"study_design_scores_gemma":[0.0000059256154,0.000030571897,0.9990395,0.0000094125735,0.000014400364,0.000041352057,0.00042203302,0.0001289152,0.000047201265,0.000004555557,0.00025065808,0.000005412516],"about_ca_topic_score_codex":0.983309,"about_ca_topic_score_gemma":0.9872372,"teacher_disagreement_score":0.019171847,"about_ca_system_score_codex":0.019171847,"about_ca_system_score_gemma":0.021102352,"threshold_uncertainty_score":0.13910216},"labels":[],"label_agreement":null},{"id":"W2105397205","doi":"10.18553/jmcp.2005.11.6.480","title":"Consumer Understanding and Satisfaction Associated With a 3-Tier Prescription Drug Benefit","year":2005,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Merck Company Foundation","keywords":"Copayment; Medicine; Medical prescription; Prescription drug; Beneficiary; Formulary; Family medicine; Drug; Health care; Psychiatry; Pharmacology; Health insurance","score_opus":0.056430990078421256,"score_gpt":0.3168114739336097,"score_spread":0.2603804838551884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105397205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921787,0.000057657526,0.000047608155,0.00006330551,0.0000018325272,0.0000059645554,0.000041553445,0.0000012666602,0.0005629188],"genre_scores_gemma":[0.99962795,0.00003867745,0.00007741058,0.000029948247,0.000005479543,0.0000044744907,0.000060224847,6.805566e-7,0.00015513295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858046,0.0005909138,0.00013583605,0.000073958996,0.00047090463,0.00014796335],"domain_scores_gemma":[0.9921927,0.0025662736,0.0036983287,0.00016618252,0.0007793407,0.0005971641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015412964,0.00014547295,0.0002834758,0.00045317275,0.00025414187,0.0008592465,0.00015470067,0.00043305464,0.0050601256],"category_scores_gemma":[0.0074498462,0.0001158315,0.0005685832,0.0003533534,0.00032913167,0.00045004094,0.0004744842,0.0006351525,0.00024734865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025965396,0.00027425817,0.9916864,0.000032600048,0.00007856683,0.0000666685,0.00080054335,0.000058159174,0.0002962351,0.00002984607,0.000100822275,0.0063161994],"study_design_scores_gemma":[0.000005844452,0.00023299071,0.99837023,0.00000795729,0.000019417681,0.00010950236,0.0007446096,0.0002563431,0.000069161535,0.000015890626,0.000163699,0.0000045825836],"about_ca_topic_score_codex":0.0024315037,"about_ca_topic_score_gemma":0.0022919201,"teacher_disagreement_score":0.0050601256,"about_ca_system_score_codex":0.0003912055,"about_ca_system_score_gemma":0.0002704766,"threshold_uncertainty_score":0.016927838},"labels":[],"label_agreement":null},{"id":"W2105612516","doi":"10.18553/jmcp.2009.15.4.312","title":"Direct All-Cause Health Care Costs Associated With Chronic Kidney Disease in Patients With Diabetes and Hypertension: A Managed Care Perspective","year":2009,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Diabetes mellitus; Kidney disease; Disease; Renal function; Managed care; Pediatrics; Intensive care medicine; Health care; Internal medicine; Endocrinology","score_opus":0.01142583061397372,"score_gpt":0.28017215693212655,"score_spread":0.2687463263181528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105612516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92251676,0.015796442,0.00543849,0.018372724,0.00038180567,0.00024691212,0.018444004,0.000030741125,0.01877208],"genre_scores_gemma":[0.98855394,0.0037017316,0.0022044117,0.0007281464,0.00038346808,0.00006556763,0.0037971924,0.0000066839375,0.00055881444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979881,0.0010490415,0.00015443022,0.00015117503,0.00039890784,0.00025836166],"domain_scores_gemma":[0.9973545,0.00080936926,0.0009130761,0.000058512454,0.00046533428,0.00039911296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015810836,0.000598828,0.0005570432,0.002014603,0.00043306057,0.002037465,0.00058320287,0.0007960666,0.0034601302],"category_scores_gemma":[0.0056424276,0.00030521853,0.0021725015,0.0028765313,0.0002958595,0.0015494882,0.00083648524,0.001638896,0.00015590682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008344151,0.0005154706,0.90068644,0.0004982344,0.005402394,0.0012750956,0.00040244625,0.028332092,0.00056937936,0.015441753,0.009662263,0.03638005],"study_design_scores_gemma":[0.0002831552,0.00089339074,0.88773835,0.00075276115,0.0030291248,0.0027152419,0.0019619642,0.07404799,0.00047529934,0.0136886155,0.014311172,0.0001030144],"about_ca_topic_score_codex":0.019932142,"about_ca_topic_score_gemma":0.03811257,"teacher_disagreement_score":0.019932142,"about_ca_system_score_codex":0.0039539514,"about_ca_system_score_gemma":0.0021025594,"threshold_uncertainty_score":0.03963226},"labels":[],"label_agreement":null},{"id":"W2109257994","doi":"10.18553/jmcp.2006.12.7.537","title":"Assessing Potentially Inappropriate Prescribing in the Elderly Veterans Affairs Population Using the HEDIS 2006 Quality Measure","year":2006,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Health Services Research and Development; U.S. Department of Veterans Affairs","keywords":"Medicine; Beers Criteria; Veterans Affairs; Logistic regression; Medical Expenditure Panel Survey; Population; Family medicine; Emergency medicine; Health care; Gerontology; Geriatrics; Environmental health; Health insurance; Internal medicine; Psychiatry","score_opus":0.2019064082309326,"score_gpt":0.44626545093116937,"score_spread":0.24435904270023678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109257994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805957,0.0020802042,0.0016413876,0.0006572526,0.000029760262,0.00029001958,0.011358186,0.000055102555,0.0032923738],"genre_scores_gemma":[0.9928924,0.0005052723,0.0018962163,0.00019099368,0.0000322037,0.0001116756,0.0042152833,0.0000047774315,0.00015125482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99362093,0.0016169646,0.001838586,0.00040041903,0.0023067205,0.00021649752],"domain_scores_gemma":[0.9783367,0.0024883354,0.0150587745,0.0005084171,0.0027937286,0.00081412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065069757,0.00024690895,0.000567959,0.003964979,0.0002808874,0.0011158107,0.00046022737,0.00037602367,0.0007727576],"category_scores_gemma":[0.014639602,0.0001711797,0.0012198037,0.0040154806,0.00019878375,0.00062504486,0.00072234333,0.0004399847,0.00016341048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004588441,0.00003293914,0.9964896,0.00004230256,0.00015012744,0.000008784411,0.000027222091,0.0001546844,0.00002532195,0.000029194847,0.000490504,0.00250344],"study_design_scores_gemma":[0.000013999907,0.00012328564,0.99795413,0.00003997936,0.00006629389,0.00007672331,0.000056956513,0.0010356945,0.0000713528,0.000046147317,0.0005087655,0.0000065441386],"about_ca_topic_score_codex":0.018563194,"about_ca_topic_score_gemma":0.016507301,"teacher_disagreement_score":0.018563194,"about_ca_system_score_codex":0.0016861727,"about_ca_system_score_gemma":0.0011291552,"threshold_uncertainty_score":0.036910236},"labels":[],"label_agreement":null},{"id":"W2110607907","doi":"10.18553/jmcp.2005.11.9.746","title":"Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration","year":2005,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Generic drug; Prescription drug; Medicine; Marketing; Medical prescription; Brand extension; Brand loyalty; Product (mathematics); Advertising; Market share; Brand names; Panel data; Expiration date; Drug; Business; Brand management; Economics; Pharmacology","score_opus":0.09298290153023488,"score_gpt":0.3140020313484577,"score_spread":0.22101912981822286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110607907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889094,0.00017067352,0.0002500576,0.000054681168,0.0000010330422,0.000009675816,0.000014256899,0.0000024211279,0.000606211],"genre_scores_gemma":[0.9994629,0.00006986916,0.00019739845,0.000015135345,0.0000061924525,0.0000025587851,0.000024905155,8.429276e-7,0.00022019059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995901,0.00014073521,0.000033620483,0.00006270755,0.00008883773,0.00008398371],"domain_scores_gemma":[0.99540114,0.0015479678,0.002275856,0.00019423987,0.0002484143,0.00033246737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012842952,0.00018508134,0.0002262216,0.0006467695,0.0002276653,0.0010796578,0.0004043936,0.00046446334,0.0030080702],"category_scores_gemma":[0.0073085595,0.00015603397,0.00032758334,0.00042246497,0.00048128,0.0013698041,0.00053653406,0.0005733225,0.000250552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009472402,0.00089539285,0.9352583,0.00008346886,0.00009119981,0.0011153343,0.0012583503,0.0012881323,0.007017578,0.0022882384,0.00017851155,0.049578182],"study_design_scores_gemma":[0.000051176776,0.00086937856,0.9856553,0.00002247107,0.000056582412,0.0013920187,0.0006981963,0.0073139896,0.0015326241,0.0014524347,0.0009359402,0.000019940033],"about_ca_topic_score_codex":0.0009496767,"about_ca_topic_score_gemma":0.0007416925,"teacher_disagreement_score":0.0030080702,"about_ca_system_score_codex":0.0004199991,"about_ca_system_score_gemma":0.00032159255,"threshold_uncertainty_score":0.010062993},"labels":[],"label_agreement":null},{"id":"W2112369566","doi":"10.18553/jmcp.2005.11.1.25","title":"The Impact of Chronic Obstructive Pulmonary Disease on Long-term Disability Costs","year":2005,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; COPD; Spirometry; Asthma; Population; Disability benefits; Health care; Environmental health; Physical therapy; Gerontology; Economic growth; Social security","score_opus":0.02205235405781437,"score_gpt":0.36751747414525054,"score_spread":0.3454651200874362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112369566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7488165,0.11559156,0.0033600372,0.04108488,0.0011586696,0.00017114541,0.024249166,0.000089307265,0.06547871],"genre_scores_gemma":[0.98260456,0.012425614,0.0005628935,0.00083573675,0.00042076941,0.00003907248,0.0021765588,0.000008124116,0.0009266356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970188,0.0010928314,0.00032392496,0.00015788212,0.00094534695,0.00046129205],"domain_scores_gemma":[0.990334,0.0028387816,0.0028398526,0.0002168001,0.002702057,0.0010685134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025016812,0.0003967143,0.0003652171,0.0017899342,0.0005877583,0.0015890056,0.00051072164,0.0005772037,0.0038581095],"category_scores_gemma":[0.01177033,0.000116919226,0.0010559924,0.001887052,0.0005776401,0.0009560571,0.0015193339,0.00094855897,0.00038829964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001602421,0.00014096439,0.84415025,0.0012774568,0.0010128057,0.00038840328,0.00020824287,0.0033418844,0.00023919214,0.00514567,0.010715867,0.13321905],"study_design_scores_gemma":[0.000016720422,0.000161238,0.9786335,0.0013528917,0.0003367368,0.00069850084,0.0004887927,0.0016677806,0.00012589087,0.0019415453,0.014551866,0.000024497],"about_ca_topic_score_codex":0.020088749,"about_ca_topic_score_gemma":0.032567963,"teacher_disagreement_score":0.020088749,"about_ca_system_score_codex":0.0025497843,"about_ca_system_score_gemma":0.0030454365,"threshold_uncertainty_score":0.039943635},"labels":[],"label_agreement":null},{"id":"W2117516569","doi":"10.18553/jmcp.2007.13.8.677","title":"Factors Associated With Choice of Pharmacy Setting Among DoD Health Care Beneficiaries Aged 65 Years or Older","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Machine Intelligence Institute; U.S. Department of Defense","keywords":"Medicine; Pharmacy; Gerontology; Family medicine; Health care","score_opus":0.07854000265562466,"score_gpt":0.39070662985506566,"score_spread":0.312166627199441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117516569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998678,0.00022363786,0.000026234271,0.000098495635,0.0000050507415,0.000007803696,0.00053194107,0.0000026102389,0.00042615595],"genre_scores_gemma":[0.99913967,0.00013301287,0.000049743823,0.000041542666,0.000010572835,0.000007454713,0.0004691079,0.0000012238199,0.0001477393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971956,0.000050607487,0.000047669724,0.00004903727,0.00006844346,0.000064667314],"domain_scores_gemma":[0.9977654,0.00033941798,0.0012947659,0.0000673913,0.00018760661,0.00034535342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003582682,0.00016877888,0.00020198473,0.00086711964,0.00056710513,0.00050408096,0.00028236743,0.00046990687,0.0024488962],"category_scores_gemma":[0.002601668,0.00018335224,0.0003407677,0.001096785,0.00017744557,0.0003104169,0.00039771723,0.00060656836,0.00023478745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013601431,0.000018115252,0.9994062,0.0000029990915,0.00000806111,0.000018095154,0.000027217173,0.000012410433,0.000026265345,0.000004016157,0.00009168336,0.00037133516],"study_design_scores_gemma":[0.0000014515458,0.000025018055,0.9995778,0.0000064406404,0.0000069070375,0.00007672913,0.00013917508,0.00006280583,0.000008870554,0.0000042476718,0.00008920042,0.0000011924978],"about_ca_topic_score_codex":0.029543996,"about_ca_topic_score_gemma":0.0492112,"teacher_disagreement_score":0.029543996,"about_ca_system_score_codex":0.00034201128,"about_ca_system_score_gemma":0.00042050844,"threshold_uncertainty_score":0.058744073},"labels":[],"label_agreement":null},{"id":"W2134015462","doi":"10.18553/jmcp.2007.13.3.245","title":"Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Glatiramer acetate; Multiple sclerosis; Expanded Disability Status Scale; Cohort; Internal medicine; Relapsing remitting; Disease; Physical therapy; Immunology","score_opus":0.3435434485136205,"score_gpt":0.46697527217032236,"score_spread":0.12343182365670186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134015462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8827436,0.0023191369,0.08500224,0.0075718816,0.00017220575,0.00074777484,0.008326715,0.00031351563,0.012803087],"genre_scores_gemma":[0.9834615,0.0008325306,0.006627908,0.0002892015,0.000056556113,0.0005983871,0.002195902,0.000026286967,0.005911808],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99797076,0.0011982336,0.000065442575,0.0002574341,0.000094871226,0.0004133598],"domain_scores_gemma":[0.9810342,0.01600768,0.0012763842,0.00022541273,0.0006066193,0.00084972417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067340536,0.001731088,0.0030636047,0.002166637,0.001093043,0.0025437558,0.0030351733,0.0042020683,0.010428578],"category_scores_gemma":[0.01325713,0.0015410981,0.0029172988,0.001525936,0.0021259352,0.002297057,0.0013438117,0.0030622198,0.00065235846],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071044086,0.00009899757,0.0040420545,0.000050519582,0.00011716305,0.00013727814,0.00003457759,0.9863007,0.000079875485,0.0066476124,0.0005256029,0.00125518],"study_design_scores_gemma":[0.00023785238,0.00012980022,0.0009908153,0.000032551998,0.00010884255,0.00004111,0.000033560525,0.9943183,0.000035274355,0.0038639756,0.00018454013,0.00002342719],"about_ca_topic_score_codex":0.04816575,"about_ca_topic_score_gemma":0.022578219,"teacher_disagreement_score":0.04816575,"about_ca_system_score_codex":0.006402753,"about_ca_system_score_gemma":0.004110753,"threshold_uncertainty_score":0.095770776},"labels":[],"label_agreement":null},{"id":"W2136365330","doi":"10.18553/jmcp.2002.8.5.372","title":"Preventable Drug-related Morbidity Indicators in the U.S. and U.K.","year":2002,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine, Dalhousie University; Dalhousie University","keywords":"Delphi method; Medicine; Viewpoints; Relevance (law); Health care; Quality (philosophy); Delphi; Sample (material); Pharmacy; Family medicine; Statistics; Political science","score_opus":0.09606945741123855,"score_gpt":0.3869771716405904,"score_spread":0.29090771422935185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136365330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830033,0.0021390626,0.00096857885,0.0034447405,0.000075541306,0.00021895363,0.0015501969,0.00002773682,0.008571989],"genre_scores_gemma":[0.9961598,0.0008130821,0.0017065312,0.00035205245,0.000008997334,0.00011769911,0.0006376999,0.000004860335,0.00019919306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99153066,0.0037862598,0.0015862113,0.00037031996,0.0021195996,0.0006069451],"domain_scores_gemma":[0.97539264,0.0069929687,0.008581178,0.0006045593,0.007167266,0.0012614604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074582463,0.000248007,0.00030968705,0.002972407,0.000820731,0.0013007263,0.0003923394,0.00035630885,0.0009438737],"category_scores_gemma":[0.026680242,0.00017757929,0.0004752811,0.0036650435,0.0011041032,0.0012538054,0.0025777195,0.0005550891,0.00013621456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003376896,0.00011567865,0.85753596,0.0022465284,0.00017426739,0.00028872088,0.031525537,0.0013854882,0.0010128065,0.002485553,0.005361864,0.09752981],"study_design_scores_gemma":[0.000009504212,0.00027800395,0.9610604,0.0007830096,0.00004189242,0.00019619169,0.026551863,0.0004918871,0.00048115492,0.00030130084,0.009761608,0.00004326619],"about_ca_topic_score_codex":0.045139354,"about_ca_topic_score_gemma":0.056578122,"teacher_disagreement_score":0.045139354,"about_ca_system_score_codex":0.005456653,"about_ca_system_score_gemma":0.0075365906,"threshold_uncertainty_score":0.08975321},"labels":[],"label_agreement":null},{"id":"W2141292679","doi":"10.18553/jmcp.2006.12.5.371","title":"Effect of a Therapeutic Maximum Allowable Cost (MAC) Program on the Cost and Utilization of Proton Pump Inhibitors in an Employer-Sponsored Drug Plan in Canada","year":2006,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Health; Royal Columbian Hospital","funders":"","keywords":"Medicine; Plan (archaeology); Drug; Operations management; Actuarial science; Pharmacology; Engineering; Business","score_opus":0.1770856332218254,"score_gpt":0.4106357295729452,"score_spread":0.23355009635111978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141292679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996849,0.00024117381,0.000052329437,0.0006443998,0.000019325718,0.00016074358,0.00037509264,0.000010556214,0.0016472235],"genre_scores_gemma":[0.9983557,0.00018215655,0.00020827248,0.0002536943,0.000009471924,0.000042454794,0.0003181721,0.0000023924076,0.00062772346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750453,0.0004198979,0.00008747594,0.00018411028,0.0007386518,0.0010652909],"domain_scores_gemma":[0.99403256,0.00060088286,0.00086012017,0.00011298354,0.0012994575,0.003093959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013607636,0.00035199238,0.00037639344,0.00072897313,0.0020290946,0.0013273206,0.0012725203,0.00074867805,0.0016935752],"category_scores_gemma":[0.0064812554,0.00025457208,0.0007314145,0.0010790635,0.0007510107,0.00041086678,0.0011570592,0.00098928,0.00007038664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009610991,0.009328506,0.8815934,0.00028256758,0.0005494497,0.0004254559,0.0014878277,0.004712641,0.0012734879,0.0015100143,0.007890991,0.081334695],"study_design_scores_gemma":[0.0009918385,0.0029581755,0.9858326,0.0000717365,0.00022808489,0.00006703662,0.0017712469,0.0053564594,0.0003326629,0.000094585674,0.0022573636,0.000038228605],"about_ca_topic_score_codex":0.9779618,"about_ca_topic_score_gemma":0.9835873,"teacher_disagreement_score":0.048665397,"about_ca_system_score_codex":0.048665397,"about_ca_system_score_gemma":0.06077353,"threshold_uncertainty_score":0.3530938},"labels":[],"label_agreement":null},{"id":"W2143960546","doi":"10.18553/jmcp.2004.10.6.531","title":"Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia","year":2004,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Dosing; Anemia; Epoetin alfa; Confidence interval; Regimen; Total cost; Emergency medicine; Internal medicine","score_opus":0.04392539738589477,"score_gpt":0.3600504343334252,"score_spread":0.3161250369475304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143960546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860638,0.0055323364,0.0044565313,0.0012552812,0.00004834346,0.00067447126,0.00032485637,0.000028905875,0.0016155604],"genre_scores_gemma":[0.99553657,0.0006512401,0.0027885714,0.00014621287,0.000026665026,0.00030169927,0.00024157725,0.0000054223265,0.0003020545],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9951178,0.004207297,0.00011417003,0.00018068,0.00022240325,0.00015770557],"domain_scores_gemma":[0.9920697,0.00633656,0.0008337997,0.00013623628,0.00033382932,0.0002898648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061825686,0.001424648,0.0016368133,0.0018040403,0.00030733523,0.0012396837,0.001213147,0.0010743728,0.0024940928],"category_scores_gemma":[0.014497215,0.00075020426,0.0042882077,0.0011311576,0.00046970506,0.00093289954,0.0007424053,0.000984936,0.00008485917],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09275128,0.005914481,0.051681273,0.002387893,0.015657175,0.000656819,0.0001930413,0.71671957,0.0026719016,0.0046779253,0.0018075835,0.104881056],"study_design_scores_gemma":[0.020318717,0.039664734,0.07239207,0.00072469364,0.019598609,0.00062073267,0.0005938737,0.8355254,0.002437318,0.0057687927,0.002168242,0.00018682607],"about_ca_topic_score_codex":0.0075580706,"about_ca_topic_score_gemma":0.004674165,"teacher_disagreement_score":0.0075580706,"about_ca_system_score_codex":0.0050574807,"about_ca_system_score_gemma":0.003037135,"threshold_uncertainty_score":0.036694765},"labels":[],"label_agreement":null},{"id":"W2144636396","doi":"10.18553/jmcp.2009.15.s1.18","title":"The Future of Medicare Part D Drug Plans—Results From a Roundtable Discussion","year":2009,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"","keywords":"Prescription drug; Medicare Part D; Beneficiary; Medicine; Government (linguistics); Sustainability; Health care; Modernization theory; Medicare Advantage; Population; Medicaid; Actuarial science; Patient Protection and Affordable Care Act; Medical prescription; Public economics; Finance; Business; Economic growth; Environmental health; Economics; Nursing","score_opus":0.02795174814693361,"score_gpt":0.33255021275584884,"score_spread":0.3045984646089152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144636396","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047168974,0.06004729,0.00064248283,0.90113646,0.012344597,0.00009378568,0.0006026382,0.00005659348,0.020359205],"genre_scores_gemma":[0.13146329,0.18369624,0.00663823,0.6117116,0.030871945,0.0005385847,0.003010351,0.00013528045,0.031934552],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.99003804,0.0028138445,0.00058501016,0.0006923344,0.004142336,0.001728394],"domain_scores_gemma":[0.97369194,0.013937505,0.0016287797,0.0006146454,0.00506278,0.0050643957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02944388,0.0009016284,0.00049814134,0.0012636923,0.003538177,0.013724489,0.0024451402,0.013743568,0.0144077595],"category_scores_gemma":[0.028244331,0.00051648985,0.001842497,0.0014685253,0.0020448081,0.013357335,0.0051945774,0.010946215,0.001620019],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016884944,0.0002798505,0.0027240554,0.00076395174,0.000054570675,0.00026248698,0.0010218375,0.00066716643,0.00026196422,0.058489453,0.7680142,0.16729164],"study_design_scores_gemma":[0.00007695642,0.00022294512,0.011548964,0.0032038356,0.000049334467,0.00011507071,0.0025373884,0.00046761398,0.0003385077,0.0141331,0.9672367,0.00006960327],"about_ca_topic_score_codex":0.017451655,"about_ca_topic_score_gemma":0.026237946,"teacher_disagreement_score":0.02944388,"about_ca_system_score_codex":0.012137503,"about_ca_system_score_gemma":0.02348209,"threshold_uncertainty_score":0.15571594},"labels":[],"label_agreement":null},{"id":"W2151986070","doi":"10.18553/jmcp.2003.9.2.134","title":"Indicators of Preventable Drug-related Morbidity in Older Adults","year":2003,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Logistic regression; Medical prescription; Incidence (geometry); Health care; Environmental health; Nursing; Internal medicine","score_opus":0.044766617435349744,"score_gpt":0.3840983321694234,"score_spread":0.33933171473407364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151986070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733055,0.000430583,0.00030563626,0.00013444784,0.000006196112,0.000041783038,0.0012230583,0.000010942782,0.0005168269],"genre_scores_gemma":[0.99835914,0.00014761924,0.00039445324,0.00002747981,0.00001590256,0.000024883135,0.0009733843,8.964923e-7,0.000056122943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989411,0.0002658287,0.0002028242,0.000119145756,0.00037581104,0.00009527398],"domain_scores_gemma":[0.9944892,0.00057004415,0.0039186613,0.00013142763,0.0004968644,0.00039379942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012280219,0.00022060952,0.00025864603,0.0016283612,0.00022026041,0.00048127634,0.00027347048,0.0002605429,0.0005804357],"category_scores_gemma":[0.007731502,0.00012843967,0.00029158933,0.0013034566,0.00012662771,0.00048002697,0.0005300981,0.0003804597,0.000093355346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012213211,0.000011666071,0.99899334,0.000006670731,0.0000124215,0.000008226122,0.000013243542,0.000017271632,0.000018042969,0.00000551994,0.000050917122,0.0008504384],"study_design_scores_gemma":[0.000003961345,0.000050208193,0.99946207,0.00000828581,0.00001086425,0.00008190765,0.000035623525,0.0001811826,0.000050486487,0.000008334216,0.00010590898,0.0000012099499],"about_ca_topic_score_codex":0.006106799,"about_ca_topic_score_gemma":0.007978622,"teacher_disagreement_score":0.006106799,"about_ca_system_score_codex":0.00046908157,"about_ca_system_score_gemma":0.00058898027,"threshold_uncertainty_score":0.012142479},"labels":[],"label_agreement":null},{"id":"W2154125954","doi":"10.18553/jmcp.2014.20.5.477","title":"Adherence Patterns for Abiraterone Acetate and Concomitant Prednisone Use in Patients with Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Abiraterone acetate; Prednisone; Concomitant; Prostate cancer; Internal medicine; Medical prescription; Population; Cancer; Androgen deprivation therapy; Oncology; Pharmacology","score_opus":0.03293191264913797,"score_gpt":0.33480896597467863,"score_spread":0.30187705332554066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154125954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893008,0.00043448393,0.00010788552,0.00027951712,0.000007761884,0.000027914566,0.009073413,0.000010917435,0.0007571943],"genre_scores_gemma":[0.99424547,0.0001295409,0.00015129868,0.00007397784,0.000010002305,0.000035916575,0.00524619,0.0000024233575,0.000105246836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978631,0.00051056605,0.0004417816,0.0004855329,0.0005374887,0.0001615557],"domain_scores_gemma":[0.9946337,0.0009331695,0.0033075104,0.00034192664,0.00047720305,0.0003065116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013487545,0.00017506252,0.00039732974,0.0013092228,0.00036123465,0.00066627417,0.0005755301,0.00053978,0.0014101679],"category_scores_gemma":[0.0061430917,0.00017740921,0.0007523205,0.0030465717,0.00017658477,0.00037712886,0.0005389572,0.0007643455,0.00022169313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040574603,0.000033233122,0.99831676,0.000015363108,0.00007130668,0.000009222398,0.000042039133,0.00007207549,0.00002594965,0.000015314237,0.0003097131,0.0010485112],"study_design_scores_gemma":[0.000009321179,0.000032201202,0.9989936,0.000015282381,0.000022770553,0.000062885425,0.0000950143,0.00040386006,0.000026239304,0.000026044421,0.00030802784,0.000004682672],"about_ca_topic_score_codex":0.018809544,"about_ca_topic_score_gemma":0.02436735,"teacher_disagreement_score":0.018809544,"about_ca_system_score_codex":0.0006927899,"about_ca_system_score_gemma":0.00067607185,"threshold_uncertainty_score":0.037400126},"labels":[],"label_agreement":null},{"id":"W2158467616","doi":"10.18553/jmcp.2009.15.1.71","title":"Prior Authorization and Clopidogrel Use - The Truth Lies in the Details","year":2009,"lang":"en","type":"editorial","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prior authorization; Clopidogrel; Authorization; Internal medicine; Aspirin; Pharmacology; Computer security","score_opus":0.05385844944678472,"score_gpt":0.3197232124911843,"score_spread":0.26586476304439954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158467616","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001164633,0.011884646,0.0001237827,0.102546476,0.8841662,0.000014608013,0.0000740086,0.000036638066,0.0010371885],"genre_scores_gemma":[0.0009046652,0.0058205808,0.000085583066,0.0288247,0.9619539,0.000015844354,0.000018483095,0.000019902367,0.0023564138],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99431866,0.0013987846,0.0011459109,0.0007659286,0.0020469846,0.0003237129],"domain_scores_gemma":[0.958324,0.028852036,0.0016224919,0.0010423335,0.00812429,0.0020349007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0097483825,0.0034374748,0.003765487,0.002323388,0.0028554408,0.0055397786,0.0040326845,0.023762472,0.0070366138],"category_scores_gemma":[0.04871322,0.0014451466,0.0022364394,0.0017875886,0.0036354961,0.00616953,0.0012184683,0.032016397,0.0038120504],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059674654,0.00002234541,0.00009780171,0.00022432877,0.000024457004,0.00013241445,0.00002483144,0.000032931093,0.000023909013,0.0006250964,0.9928402,0.005892048],"study_design_scores_gemma":[0.00033729832,0.00010203597,0.0018490808,0.002053922,0.00018791841,0.000671258,0.00016787581,0.0006574964,0.00021905701,0.004291931,0.98939973,0.000062471205],"about_ca_topic_score_codex":0.00462009,"about_ca_topic_score_gemma":0.0075159892,"teacher_disagreement_score":0.023762472,"about_ca_system_score_codex":0.003494127,"about_ca_system_score_gemma":0.0037114643,"threshold_uncertainty_score":0.051554978},"labels":[],"label_agreement":null},{"id":"W2162799816","doi":"10.18553/jmcp.2007.13.3.262","title":"Actuarial Analysis of Private Payer Administrative Claims Data for Women With Endometriosis","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endometriosis; Diagnosis code; Pelvic pain; Referral; Health care; Retrospective cohort study; Medical record; Family medicine; Demography; Environmental health; Gynecology; Population; Internal medicine; Surgery","score_opus":0.1022879110438829,"score_gpt":0.43469814236562404,"score_spread":0.33241023132174113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162799816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96464515,0.0007385155,0.0038708532,0.00020050547,0.000030756077,0.00016702959,0.028176593,0.00008436135,0.0020863402],"genre_scores_gemma":[0.98261535,0.0002176344,0.0009140011,0.000039253566,0.00004214865,0.00008848189,0.015830327,0.000009791461,0.00024294875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956052,0.0016082568,0.0006986509,0.00071321195,0.00096509396,0.00040949055],"domain_scores_gemma":[0.9595252,0.020517498,0.012612984,0.0042158207,0.0024732319,0.00065527373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010449296,0.00027672984,0.000557078,0.003537098,0.00030850596,0.0010237459,0.0006784565,0.00042902929,0.0027682434],"category_scores_gemma":[0.029225944,0.0003170448,0.0012680842,0.0028318227,0.0002596076,0.00072737737,0.0008723925,0.0006058103,0.0005256715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005820884,0.00008914871,0.9842976,0.00007006484,0.00057195337,0.00015860194,0.000066384084,0.0044869278,0.00012433348,0.0004098541,0.001787185,0.0073558944],"study_design_scores_gemma":[0.000043394568,0.00025509903,0.96602315,0.00004068988,0.0002630695,0.00042972385,0.00011743808,0.03040588,0.00020033399,0.00053188606,0.0016653887,0.000023818773],"about_ca_topic_score_codex":0.0066709844,"about_ca_topic_score_gemma":0.0035215637,"teacher_disagreement_score":0.010449296,"about_ca_system_score_codex":0.0009604943,"about_ca_system_score_gemma":0.0006422254,"threshold_uncertainty_score":0.05526179},"labels":[],"label_agreement":null},{"id":"W2180208706","doi":"10.18553/jmcp.2012.18.5.363","title":"All-Cause and Potentially Disease-Related Health Care Costs Associated with Venous Thromboembolism in Commercial, Medicare, and Medicaid Beneficiaries","year":2012,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"University of Illinois at Chicago; University of Illinois at Urbana-Champaign; Janssen Scientific Affairs","keywords":"Medicine; Pulmonary embolism; Medicaid; Diagnosis code; Venous thrombosis; Deep vein; Disease; Pediatrics; Thrombosis; Intensive care medicine; Health care; Emergency medicine; Surgery; Internal medicine; Population","score_opus":0.022788755898265893,"score_gpt":0.31959373641083144,"score_spread":0.29680498051256554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180208706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545586,0.0005135426,0.000081029284,0.00022184891,0.0000071101813,0.000025856561,0.003120987,0.0000037254385,0.0005700407],"genre_scores_gemma":[0.9967559,0.00027734623,0.00013237006,0.000039571216,0.000022010337,0.000025041938,0.0026418339,0.0000012613071,0.000104636776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911994,0.00028509245,0.00014310064,0.00008834969,0.00022369991,0.00013987478],"domain_scores_gemma":[0.9976931,0.000492772,0.0013480344,0.000066668516,0.00014840763,0.00025096544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070774823,0.00020151288,0.0002467226,0.0013081826,0.00030033532,0.00052603765,0.00040371795,0.00034505595,0.0017094079],"category_scores_gemma":[0.0054792124,0.00015633032,0.00065298454,0.0015774402,0.00017713859,0.00049814896,0.00076796167,0.0005832104,0.0000650232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020567446,0.0000617827,0.99596834,0.00002813885,0.00013065836,0.000082001614,0.000026946886,0.0006243461,0.00004915189,0.00013824667,0.0003628127,0.002321907],"study_design_scores_gemma":[0.000015186807,0.000050880128,0.99752146,0.000018015045,0.0000672542,0.00019677542,0.00007212942,0.0017396731,0.000031904045,0.00009291166,0.0001899058,0.0000037763782],"about_ca_topic_score_codex":0.023126598,"about_ca_topic_score_gemma":0.024840683,"teacher_disagreement_score":0.023126598,"about_ca_system_score_codex":0.0015863094,"about_ca_system_score_gemma":0.0007695807,"threshold_uncertainty_score":0.04598397},"labels":[],"label_agreement":null},{"id":"W2187411263","doi":"10.18553/jmcp.2010.16.9.680","title":"Evaluation of Health Plan Member Use of an Online Prescription Drug Price Comparison Tool","year":2010,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Copayment; Medicine; Pharmacy; Quarter (Canadian coin); Medical prescription; Prescription drug; Family medicine; Demographics; Health care; Demography; Nursing","score_opus":0.28205228986199204,"score_gpt":0.45511176631584055,"score_spread":0.1730594764538485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187411263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826235,0.0001973436,0.0019843073,0.00072367024,0.000071940325,0.007668009,0.0018609439,0.00021892623,0.0046513597],"genre_scores_gemma":[0.97118604,0.00017578996,0.014848178,0.0003354407,0.00007538226,0.011005797,0.0017869086,0.00003525287,0.00055119634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8882585,0.083080165,0.007875563,0.002784885,0.016283674,0.0017171797],"domain_scores_gemma":[0.74827385,0.17180257,0.03350554,0.010466997,0.030102005,0.0058490173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.099829964,0.0011292563,0.0010306932,0.0026714457,0.001135695,0.0024582,0.002566006,0.0016570251,0.0034001444],"category_scores_gemma":[0.17425266,0.0006676726,0.002070134,0.0021644065,0.0008424709,0.0030947279,0.0025326202,0.0014536392,0.00053798023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023691643,0.042174064,0.68203056,0.0012904893,0.0014032999,0.00025709716,0.004266239,0.0037643178,0.0009900188,0.000344044,0.004450125,0.23533817],"study_design_scores_gemma":[0.0062448457,0.101443976,0.8368886,0.0007918738,0.0016297747,0.00042359522,0.0052394425,0.032493185,0.005934029,0.00039270602,0.008260265,0.0002576881],"about_ca_topic_score_codex":0.004280968,"about_ca_topic_score_gemma":0.0036689988,"teacher_disagreement_score":0.099829964,"about_ca_system_score_codex":0.003691348,"about_ca_system_score_gemma":0.0052096695,"threshold_uncertainty_score":0.5279576},"labels":[],"label_agreement":null},{"id":"W2188680388","doi":"10.18553/jmcp.2003.9.6.523","title":"Financial Risk Relationships and Adoption of Management Strategies in Physician Groups for Self-Administered Injectable Drugs","year":2003,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"AcademyHealth; Robert Wood Johnson Foundation","keywords":"Capitation; Medicine; Pharmacy; Family medicine; Health maintenance; Risk management; Financial risk; Finance; Health care; Business","score_opus":0.03690324769388929,"score_gpt":0.32261147775706933,"score_spread":0.28570823006318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188680388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949837,0.00006884895,0.00005369121,0.000102036196,0.0000015720309,0.0000076274764,0.000006808043,5.7104353e-7,0.00026050888],"genre_scores_gemma":[0.9997662,0.0000326449,0.00008865971,0.000021912467,0.00000471551,0.000004525728,0.000011877537,3.8264335e-7,0.000069008885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971323,0.0013320935,0.00021734569,0.0002526747,0.0006539077,0.00041170613],"domain_scores_gemma":[0.97414374,0.008439141,0.0139544485,0.00038698473,0.00097633986,0.0020993366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027386332,0.0002483106,0.00016259759,0.0009551229,0.00069439015,0.000991223,0.00035200675,0.0006746395,0.0022811508],"category_scores_gemma":[0.02572571,0.00018818944,0.00025538015,0.0005585907,0.00068073923,0.0009069229,0.0009202531,0.00071733794,0.00012463471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006555845,0.00023975961,0.9948966,0.000005834919,0.000020080515,0.0000832207,0.0013217652,0.000044631575,0.00013967314,0.000043300715,0.000037607828,0.0031019065],"study_design_scores_gemma":[0.000013352221,0.00026293963,0.9950907,0.00001512585,0.000011322355,0.0004337075,0.003367695,0.00045831956,0.00009434347,0.000072741364,0.00017412129,0.000005538531],"about_ca_topic_score_codex":0.0036562125,"about_ca_topic_score_gemma":0.004725906,"teacher_disagreement_score":0.0036562125,"about_ca_system_score_codex":0.0007855847,"about_ca_system_score_gemma":0.000740343,"threshold_uncertainty_score":0.014483511},"labels":[],"label_agreement":null},{"id":"W2189198699","doi":"10.18553/jmcp.2003.9.4.353","title":"The Economic Impact of Acute Exacerbations of Chronic Bronchitis in the United States and Canada: A Literature Review","year":2003,"lang":"en","type":"review","venue":"Journal of Managed Care Pharmacy","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"GlaxoSmithKline","keywords":"Chronic bronchitis; Medicine; Bronchitis; Intensive care medicine; Public health; MEDLINE; Health care; Health economics; Pharmacoeconomics; Internal medicine; Nursing","score_opus":0.01324600114464602,"score_gpt":0.32041036808875645,"score_spread":0.3071643669441104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189198699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006167892,0.99805164,0.000019895402,0.00043788887,0.00007268448,0.000018683319,0.000103945946,0.00000181881,0.0006765863],"genre_scores_gemma":[0.0040823678,0.9954828,0.00010843623,0.00011453947,0.00002699974,0.000013888179,0.00004093322,6.8571103e-7,0.00012930259],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983902,0.0002729117,0.00029700637,0.000089616544,0.0008477793,0.0001025496],"domain_scores_gemma":[0.9945023,0.0025213328,0.0007919533,0.000038545317,0.0019872703,0.00015857762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022532158,0.000782722,0.002402645,0.010877289,0.0009871757,0.0030306545,0.0012444438,0.0013306064,0.0033762404],"category_scores_gemma":[0.008641147,0.00041707477,0.0012852871,0.023705391,0.0005984572,0.0010971151,0.0005470547,0.0005100926,0.00024395168],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002274888,0.00006746338,0.005882325,0.25610152,0.0016024981,0.0011233137,0.0004358304,0.0008959874,0.00019732007,0.0014518491,0.031393986,0.7006204],"study_design_scores_gemma":[0.00020696083,0.00028457088,0.06809118,0.5038364,0.012520573,0.0046878094,0.0023499734,0.0010460081,0.0005508352,0.0016345755,0.40464547,0.00014565756],"about_ca_topic_score_codex":0.39102992,"about_ca_topic_score_gemma":0.55567753,"teacher_disagreement_score":0.60897005,"about_ca_system_score_codex":0.014224679,"about_ca_system_score_gemma":0.036287416,"threshold_uncertainty_score":0.7775078},"labels":[],"label_agreement":null},{"id":"W2274300369","doi":"10.18553/jmcp.2007.13.9-c.1","title":"The Changing Landscape of Type 2 Diabetes: The Role of Incretin-Based Therapies in Managed Care Outcomes","year":2007,"lang":"en","type":"review","venue":"Journal of Managed Care Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; McGill University; U.S. Department of Veterans Affairs; University of Southern California; Eli Lilly and Company; American Diabetes Association","keywords":"Medicine; Incretin; Intensive care medicine; Exenatide; Type 2 Diabetes Mellitus; Disease; Diabetes mellitus; Type 2 diabetes; Postprandial; Sitagliptin; Bioinformatics; Internal medicine; Endocrinology","score_opus":0.030240095817671963,"score_gpt":0.34629571035188284,"score_spread":0.3160556145342109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274300369","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003333739,0.5454375,0.0025500245,0.43607518,0.0050983718,0.000033861103,0.00022507225,0.00007362166,0.0071726493],"genre_scores_gemma":[0.08123826,0.8402009,0.0062906947,0.04940122,0.021550892,0.00013603484,0.0002967638,0.00004822672,0.00083694066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949226,0.0026808518,0.0005007414,0.0002856802,0.0012565086,0.0003536542],"domain_scores_gemma":[0.9713013,0.016700722,0.0041499883,0.00049111433,0.0042973724,0.0030595616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014555981,0.00044828356,0.0010568796,0.0016610752,0.0011666563,0.00565141,0.0010871161,0.0023652336,0.0035308078],"category_scores_gemma":[0.033160914,0.00019260582,0.0009839657,0.0026076883,0.0024186175,0.0059641493,0.0030432525,0.0061699185,0.00042223991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002407349,0.0001491947,0.015784513,0.004660148,0.00032883056,0.00029173365,0.001099946,0.0011804806,0.0001967827,0.071717896,0.12959464,0.77475506],"study_design_scores_gemma":[0.0002080451,0.0006470806,0.04595811,0.05029111,0.00065267837,0.0010267436,0.0032815693,0.0040941006,0.000354762,0.16889016,0.7243447,0.00025095578],"about_ca_topic_score_codex":0.005571465,"about_ca_topic_score_gemma":0.007202474,"teacher_disagreement_score":0.014555981,"about_ca_system_score_codex":0.004800757,"about_ca_system_score_gemma":0.0081238905,"threshold_uncertainty_score":0.07698029},"labels":[],"label_agreement":null},{"id":"W2275784987","doi":"10.18553/jmcp.2007.13.7.589","title":"Perceptions of Saskatchewan Community Pharmacists Regarding a Prior-Authorization Program","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Pharmacy; Pharmacist; Family medicine; Medical prescription; Prior authorization; Authorization; Nursing","score_opus":0.12258614385582679,"score_gpt":0.46141677899021105,"score_spread":0.3388306351343843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275784987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010706,0.00018145512,0.000048451177,0.003228448,0.000014981059,0.00004531034,0.00005625556,0.0000038643034,0.0063140835],"genre_scores_gemma":[0.9964972,0.00046318505,0.00009019306,0.001411671,0.000008221257,0.00002243884,0.000036564317,0.0000017370035,0.0014688888],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99813783,0.0005130163,0.00006910312,0.000094674964,0.00056341157,0.00062192953],"domain_scores_gemma":[0.99375135,0.0009105786,0.0010284313,0.00007364901,0.0015072712,0.002728787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001700329,0.00017545541,0.00017976368,0.00048633813,0.0042473814,0.0024810503,0.00047771656,0.00070964306,0.006380051],"category_scores_gemma":[0.0049512926,0.00023529842,0.0001784179,0.0007586534,0.0010327607,0.0006853248,0.0017318183,0.0012241517,0.00034703204],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048258685,0.0009593222,0.8242809,0.00032276017,0.0000903777,0.0028403807,0.090249166,0.00031812876,0.007073585,0.00084582693,0.011806765,0.060730148],"study_design_scores_gemma":[0.00006286112,0.0005194115,0.68018633,0.00027857916,0.000040897412,0.0006678459,0.29642397,0.00039812247,0.000549431,0.0001663599,0.020651404,0.0000547603],"about_ca_topic_score_codex":0.6140811,"about_ca_topic_score_gemma":0.80538046,"teacher_disagreement_score":0.38591892,"about_ca_system_score_codex":0.008432619,"about_ca_system_score_gemma":0.024543492,"threshold_uncertainty_score":0.77638334},"labels":[],"label_agreement":null},{"id":"W2277214561","doi":"10.18553/jmcp.2006.12.5.398","title":"Pharmacy Management Methods in Canada, Including Lower-Cost Therapy for Heartburn","year":2006,"lang":"en","type":"letter","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heartburn; Pharmacy; Intensive care medicine; Physical therapy; Family medicine; Internal medicine; Reflux","score_opus":0.23345561882292634,"score_gpt":0.4970969117919088,"score_spread":0.2636412929689824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277214561","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17671368,0.0035098442,0.00014735648,0.78783447,0.0024602618,0.00010416942,0.0006538958,0.000045808218,0.028530424],"genre_scores_gemma":[0.58917505,0.003865153,0.0007967634,0.37638864,0.0048050154,0.000058459995,0.00029602743,0.00007245068,0.024542449],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797815,0.00015838181,0.00021074973,0.00014155856,0.0005998859,0.0009113618],"domain_scores_gemma":[0.99026114,0.0014292222,0.000942814,0.00009313017,0.002499692,0.004773948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087371725,0.00023579721,0.00052182976,0.00069710374,0.009369189,0.0021842571,0.0013359867,0.009826037,0.007307083],"category_scores_gemma":[0.006354691,0.00038203687,0.0005957346,0.0017200223,0.0013764938,0.0009497992,0.000761541,0.010658015,0.0003503222],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010439231,0.0014727735,0.38374087,0.00043401783,0.00016218556,0.039484393,0.0058794417,0.00084133056,0.001345246,0.003735494,0.4833831,0.078477144],"study_design_scores_gemma":[0.00073905836,0.000502213,0.7372483,0.0010843829,0.00026104908,0.018870678,0.02241496,0.0035572895,0.0006291298,0.0015917689,0.21289782,0.00020336555],"about_ca_topic_score_codex":0.96768606,"about_ca_topic_score_gemma":0.9930609,"teacher_disagreement_score":0.048787393,"about_ca_system_score_codex":0.048787393,"about_ca_system_score_gemma":0.070890285,"threshold_uncertainty_score":0.353979},"labels":[],"label_agreement":null},{"id":"W2279142588","doi":"10.18553/jmcp.2005.11.5.416","title":"Implementation of the Beers Criteria: Sticks and Stones - or Throw Me a Bone","year":2005,"lang":"en","type":"editorial","venue":"Journal of Managed Care Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. Air Force","keywords":"Medicine; Alternative medicine; Expert opinion; Evidence-based medicine; Medical education; Pathology","score_opus":0.19711295549435598,"score_gpt":0.4962707813872072,"score_spread":0.2991578258928512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279142588","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005564154,0.011162838,0.00087399886,0.071535476,0.9141812,0.00009715169,0.00012407322,0.000065355875,0.0019043759],"genre_scores_gemma":[0.0018408879,0.014433369,0.002121843,0.064906426,0.908496,0.0001967022,0.00015530153,0.00009096428,0.0077584474],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97569954,0.006982152,0.0058970936,0.001158765,0.009681895,0.00058063155],"domain_scores_gemma":[0.89564216,0.05896416,0.0047728596,0.0018794242,0.03550538,0.0032359434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025480766,0.002961515,0.006222256,0.004505633,0.0020447993,0.008681019,0.005848685,0.017267602,0.005366352],"category_scores_gemma":[0.12137294,0.0011393786,0.0033679984,0.0024725513,0.005164048,0.005062464,0.0017263136,0.029000876,0.0054318435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004555964,0.000009685278,0.000046110534,0.00050869485,0.00004769662,0.00011254471,0.000025061592,0.000044260072,0.000032659867,0.00092123233,0.98877895,0.009427528],"study_design_scores_gemma":[0.000218159,0.00006548279,0.00074848655,0.002373297,0.00022167292,0.0005950577,0.00008022652,0.0007029128,0.00031111322,0.0044063027,0.9902046,0.00007269217],"about_ca_topic_score_codex":0.002737145,"about_ca_topic_score_gemma":0.0051890067,"teacher_disagreement_score":0.025480766,"about_ca_system_score_codex":0.0041629104,"about_ca_system_score_gemma":0.006243102,"threshold_uncertainty_score":0.13475674},"labels":[],"label_agreement":null},{"id":"W2281510938","doi":"10.18553/jmcp.2007.13.9-a.1","title":"Shrinking Health Care Disparities in Women: The Depression Dilemma","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Mental Health Treatment and Access","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Royal College of Physicians and Surgeons of Canada; Kaiser Permanente","keywords":"Medicine; Dilemma; Depression (economics); Health care; Psychiatry; Gerontology; Economic growth","score_opus":0.032092387318229006,"score_gpt":0.4108677102546799,"score_spread":0.3787753229364509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281510938","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002421211,0.0069589373,0.00017962436,0.98621863,0.001192167,0.0000071387076,0.000019538646,0.0000070144993,0.0029957301],"genre_scores_gemma":[0.20543376,0.043863613,0.0024284793,0.7267865,0.01584297,0.00017107658,0.00006295567,0.000056032124,0.005354634],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9925978,0.003966445,0.0002511956,0.0004641082,0.0012568334,0.0014635079],"domain_scores_gemma":[0.9804586,0.008295869,0.0007736204,0.00052023435,0.0014017369,0.008549835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02087203,0.00052450586,0.0010184451,0.0016069915,0.007271901,0.0061277156,0.0018458422,0.0100851385,0.007961219],"category_scores_gemma":[0.02857604,0.00036982968,0.0009250953,0.0011630844,0.010283365,0.009366675,0.009817407,0.011094519,0.00078834407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018841676,0.00024555356,0.012936021,0.0006455835,0.00017199568,0.00059398555,0.012058557,0.00019281726,0.00050550175,0.14096192,0.50098974,0.33050993],"study_design_scores_gemma":[0.00044028508,0.0003809249,0.01937717,0.004688212,0.00017850203,0.0009235282,0.03792179,0.00046436986,0.0005638813,0.3136114,0.62135565,0.0000943197],"about_ca_topic_score_codex":0.012864552,"about_ca_topic_score_gemma":0.02828619,"teacher_disagreement_score":0.02087203,"about_ca_system_score_codex":0.004735823,"about_ca_system_score_gemma":0.02023947,"threshold_uncertainty_score":0.11038315},"labels":[],"label_agreement":null},{"id":"W2281697559","doi":"10.18553/jmcp.2013.19.9.740","title":"Comparative Effectiveness of Hypoglycemic Medications Among Veterans","year":2013,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of South Florida; McGill University; Florida Department of Health; U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Odds ratio; Repaglinide; Rosiglitazone; Metformin; Diabetes mellitus; Type 2 diabetes; Logistic regression; Polypharmacy; Insulin; Endocrinology","score_opus":0.02348004923849426,"score_gpt":0.32931035817338683,"score_spread":0.30583030893489255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281697559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368876,0.0046779905,0.000083989326,0.00011315049,0.000024452198,0.000030956813,0.00036121483,0.0000032750079,0.0010163431],"genre_scores_gemma":[0.9981294,0.0010998994,0.00009142105,0.000056032175,0.0000584978,0.000026650037,0.00046932686,0.0000012724951,0.00006747243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951723,0.0031615465,0.0004477931,0.000332849,0.0005953049,0.00029015468],"domain_scores_gemma":[0.9913083,0.004918095,0.0024539665,0.00024873874,0.00048704213,0.0005839547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036299385,0.00021175387,0.00060344907,0.0009871861,0.00018968378,0.00084319134,0.00024893731,0.00035252716,0.0017390621],"category_scores_gemma":[0.0124301165,0.00011930494,0.0011836613,0.0008595244,0.0003199998,0.00043034865,0.00039973197,0.00032830058,0.00013873333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041908357,0.0011625418,0.88359344,0.00053037546,0.0054349275,0.00015420944,0.00026863872,0.0006716637,0.00039856933,0.00036891637,0.00058196817,0.0649265],"study_design_scores_gemma":[0.0038356413,0.031292576,0.9563374,0.00022581615,0.0029098806,0.0005959696,0.0006915703,0.0011174612,0.0008556241,0.0003690521,0.0017321217,0.000036959293],"about_ca_topic_score_codex":0.00096221623,"about_ca_topic_score_gemma":0.0011521939,"teacher_disagreement_score":0.0036299385,"about_ca_system_score_codex":0.0006625901,"about_ca_system_score_gemma":0.0004273745,"threshold_uncertainty_score":0.019197166},"labels":[],"label_agreement":null},{"id":"W2282033865","doi":"10.18553/jmcp.2002.8.5.365","title":"Preventable Drug-related Morbidity in Older Adults-1. Indicator Development (Part 1 of a 2-part series)","year":2002,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Delphi method; Pharmaceutical care; Health care; Causality (physics); Family medicine; Pharmacy","score_opus":0.07604677687570777,"score_gpt":0.3559927667166806,"score_spread":0.27994598984097285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282033865","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7976317,0.0065085613,0.08979755,0.010051095,0.0011423562,0.044316784,0.009105065,0.00082565343,0.0406213],"genre_scores_gemma":[0.6695503,0.003920277,0.27962446,0.0007194629,0.00028299337,0.029542489,0.013021053,0.00004601049,0.0032929194],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9871343,0.0069725723,0.0025595545,0.0003043343,0.0026704841,0.00035872546],"domain_scores_gemma":[0.9677383,0.013868555,0.005462399,0.0015269284,0.009805313,0.0015984187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029996952,0.00080001156,0.0006969343,0.003429309,0.000550619,0.0012964254,0.00067165925,0.0007270524,0.002530979],"category_scores_gemma":[0.045674656,0.0003364413,0.0010592807,0.0019946804,0.0006102258,0.0018652156,0.0019860892,0.001039513,0.00041558567],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097305846,0.0016939185,0.35356405,0.00726237,0.00034887542,0.00020210049,0.0042481082,0.0059522875,0.0033904582,0.005215149,0.026726427,0.5904232],"study_design_scores_gemma":[0.0005478249,0.007741337,0.87802917,0.0037498954,0.00038535066,0.00085983024,0.0052817566,0.0108900145,0.0143057965,0.0052804495,0.07278345,0.00014516937],"about_ca_topic_score_codex":0.00094794953,"about_ca_topic_score_gemma":0.00096139335,"teacher_disagreement_score":0.029996952,"about_ca_system_score_codex":0.0020097415,"about_ca_system_score_gemma":0.0070449975,"threshold_uncertainty_score":0.15864092},"labels":[],"label_agreement":null},{"id":"W2287063926","doi":"10.18553/jmcp.2006.12.7.578","title":"PPIs Are Therapeutically Interchangeable and Ideal for a Managed Care Intervention Such as Therapeutic MAC","year":2006,"lang":"en","type":"letter","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rabeprazole; Intervention (counseling); Pharmacy; Managed care; Esomeprazole; Drug; Intensive care medicine; Activity-based costing; Therapeutic effect; Medical emergency; Emergency medicine; Pharmacology; Family medicine; Internal medicine; Proton-pump inhibitor; Nursing; Health care","score_opus":0.07558420101270502,"score_gpt":0.39766980958942366,"score_spread":0.32208560857671864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287063926","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009251048,0.0014081491,0.00017062867,0.98842674,0.005348122,0.000008085637,0.000019177829,0.000018341038,0.0036755914],"genre_scores_gemma":[0.015991624,0.0021706275,0.00093693513,0.93167204,0.045213442,0.000027589325,0.000024509547,0.000016123235,0.003947151],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99170554,0.0029626214,0.0014987012,0.0006876487,0.002581447,0.0005640781],"domain_scores_gemma":[0.97414464,0.015275686,0.0025968207,0.0009825754,0.0052415784,0.001758629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00551361,0.00038633012,0.00085537037,0.0006854391,0.0024082644,0.00271042,0.0009360063,0.023552911,0.003775973],"category_scores_gemma":[0.05202292,0.00041001223,0.0007317763,0.0008594053,0.0034645856,0.0030723421,0.0011136736,0.018866554,0.0029822334],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012185797,0.000087513574,0.0020366346,0.00012900605,0.00001884482,0.0034114872,0.00027027357,0.000075029144,0.00031114614,0.007067755,0.95189357,0.03457685],"study_design_scores_gemma":[0.0002851821,0.00020469187,0.0041963574,0.0005501914,0.000051478844,0.012056872,0.00067651307,0.0006626364,0.0005479427,0.009942809,0.9707647,0.0000606155],"about_ca_topic_score_codex":0.0032475467,"about_ca_topic_score_gemma":0.0065289084,"teacher_disagreement_score":0.023552911,"about_ca_system_score_codex":0.003297811,"about_ca_system_score_gemma":0.0031119594,"threshold_uncertainty_score":0.029159069},"labels":[],"label_agreement":null},{"id":"W2288948277","doi":"10.18553/jmcp.2008.14.s1-a.1a","title":"The Challenge of Compliance and Persistence: Focus on Ulcerative Colitis","year":2008,"lang":"en","type":"review","venue":"Journal of Managed Care Pharmacy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; McGill University; National Cancer Institute; Crohn's and Colitis Foundation of America","keywords":"Medicine; Psychosocial; Population; Ulcerative colitis; Intensive care medicine; Disease; Adverse effect; Regimen; Health care; Persistence (discontinuity); Patient education; Medication adherence; Family medicine; Internal medicine; Environmental health; Psychiatry","score_opus":0.12122900713347373,"score_gpt":0.3867234102996507,"score_spread":0.26549440316617695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288948277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005455928,0.8874916,0.0005202717,0.098016016,0.0022230218,0.000030755033,0.000021523427,0.000018683728,0.006222157],"genre_scores_gemma":[0.03840012,0.9129158,0.0010213976,0.0348202,0.010502641,0.00008978627,0.00003229853,0.000022265622,0.0021954789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973762,0.001648832,0.00018085983,0.00016882202,0.0003551612,0.00027018235],"domain_scores_gemma":[0.9892005,0.007850836,0.0007228433,0.00013109138,0.0009788942,0.0011158069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040366664,0.0006716234,0.0019567749,0.0017434866,0.0014569084,0.0027037815,0.00075032894,0.004097006,0.0026596512],"category_scores_gemma":[0.0067331227,0.00035107342,0.0008352029,0.0018994955,0.0026817673,0.0045197774,0.0031886008,0.00599242,0.00048450765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002219025,0.00032906406,0.011079033,0.01816884,0.00014686442,0.005719318,0.011900568,0.0003160042,0.00074066926,0.017535336,0.08732512,0.8465174],"study_design_scores_gemma":[0.000111222245,0.0019765687,0.058439884,0.052770216,0.00047252007,0.033164423,0.02701354,0.0005846555,0.0003926228,0.02262615,0.8022652,0.00018295436],"about_ca_topic_score_codex":0.0057355035,"about_ca_topic_score_gemma":0.012759362,"teacher_disagreement_score":0.0057355035,"about_ca_system_score_codex":0.0025047127,"about_ca_system_score_gemma":0.003666949,"threshold_uncertainty_score":0.021348178},"labels":[],"label_agreement":null},{"id":"W2292245429","doi":"10.18553/jmcp.2011.17.s9-a.s27","title":"Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research","year":2011,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"H2020 European Research Council; U.S. Food and Drug Administration; National Institutes of Health; Pfizer","keywords":"Medicine; Psychological intervention; Comparative effectiveness research; Quality of life (healthcare); Health care; Nausea; Set (abstract data type); Physical therapy; Intensive care medicine; Alternative medicine; Psychiatry; Surgery; Nursing","score_opus":0.8433772274253245,"score_gpt":0.5505320714857466,"score_spread":0.29284515593957794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292245429","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031414044,0.14105111,0.53998464,0.22531179,0.023962768,0.013230463,0.0018848652,0.0006629776,0.050770003],"genre_scores_gemma":[0.10096001,0.028806832,0.6762412,0.12358863,0.026611818,0.03891754,0.00085205754,0.0008042004,0.003217647],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.03677437,0.89631736,0.03135543,0.005167156,0.0296611,0.0007246988],"domain_scores_gemma":[0.017871134,0.9477423,0.0096629,0.012736364,0.011274402,0.0007130073],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.88901955,0.005701713,0.016651815,0.01749447,0.0038552792,0.027705824,0.025876831,0.029522453,0.011249482],"category_scores_gemma":[0.9227141,0.0049562803,0.012031319,0.026216252,0.04574619,0.029347407,0.01609005,0.039540935,0.0037170546],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035249176,0.00042573214,0.0041453587,0.028807798,0.0060947477,0.0007711073,0.0070926677,0.0058449954,0.00031272596,0.71918,0.045982894,0.1778171],"study_design_scores_gemma":[0.0020753613,0.0025943974,0.0030565392,0.08187809,0.0020701925,0.0017441165,0.002609254,0.01899379,0.0010159274,0.65678185,0.2264941,0.00068648247],"about_ca_topic_score_codex":0.00425094,"about_ca_topic_score_gemma":0.004469048,"teacher_disagreement_score":0.11098045,"about_ca_system_score_codex":0.015655255,"about_ca_system_score_gemma":0.019237231,"threshold_uncertainty_score":0.1368587},"labels":[],"label_agreement":null},{"id":"W2296952336","doi":"10.18553/jmcp.2002.8.5.406","title":"Clinical Pharmacist Interventions Associated with Appropriateness and Lengthof Inpatient Antimicrobial Therapy for Pneumonia","year":2002,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pneumonia; Psychological intervention; Pharmaceutical care; Clinical pharmacy; Pharmacist; Antimicrobial stewardship; Emergency medicine; Antibiotics; Intensive care medicine; Pharmacy; Internal medicine; Antibiotic resistance; Family medicine; Nursing","score_opus":0.12287502161693276,"score_gpt":0.3959279199479969,"score_spread":0.27305289833106416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296952336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645889,0.011872765,0.00034287476,0.019464584,0.00071683683,0.00013995948,0.0005816676,0.000048363716,0.0022441447],"genre_scores_gemma":[0.9899518,0.0028116573,0.0005794287,0.0036885615,0.0023510049,0.00009744123,0.00019947402,0.000012222411,0.00030839798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990651,0.005439248,0.00096331583,0.0005215673,0.0018981255,0.00052676955],"domain_scores_gemma":[0.8926788,0.053794023,0.043108135,0.0010114597,0.005144075,0.004263557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046983184,0.00031141704,0.0006558226,0.00082650804,0.00046650885,0.0010107601,0.0005459298,0.001569274,0.0027803276],"category_scores_gemma":[0.0728565,0.00024643153,0.00078545406,0.0011859038,0.0005073161,0.0006881456,0.0004311253,0.0015962434,0.0001955626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035278616,0.001160415,0.95279217,0.000549663,0.0009955941,0.00037280927,0.00021468551,0.00017283397,0.00015448374,0.000055514094,0.0069633536,0.033040658],"study_design_scores_gemma":[0.0003612963,0.0018710524,0.9941414,0.00019112146,0.0005048109,0.00048742036,0.000120174365,0.00070642994,0.00015805256,0.00007861116,0.0013494949,0.000030164887],"about_ca_topic_score_codex":0.0026031036,"about_ca_topic_score_gemma":0.0047476166,"teacher_disagreement_score":0.0046983184,"about_ca_system_score_codex":0.0012167043,"about_ca_system_score_gemma":0.0014340312,"threshold_uncertainty_score":0.024847388},"labels":[],"label_agreement":null},{"id":"W2299322097","doi":"10.18553/jmcp.2005.11.s1-b.1","title":"Trends in the Management of Type 2 Diabetes: An Emerging Role for Insulin","year":2005,"lang":"en","type":"review","venue":"Journal of Managed Care Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; National Institutes of Health; York University; University of Pennsylvania; GlaxoSmithKline; Washington State University; AstraZeneca; Bristol-Myers Squibb; Pfizer; Novo Nordisk; American Diabetes Association","keywords":"Medicine; Glycemic; Insulin; Type 2 diabetes; Diabetes mellitus; Intensive care medicine; Basal insulin; Pharmacy; Diabetes management; Internal medicine; Endocrinology; Family medicine","score_opus":0.07207173885985754,"score_gpt":0.4106241114465462,"score_spread":0.3385523725866887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299322097","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038318933,0.99835604,0.000041459083,0.0009920987,0.00022036897,0.0000013859066,0.0000017182937,0.000002481716,0.000346089],"genre_scores_gemma":[0.00040392738,0.99832195,0.0001506728,0.00059385714,0.0003851787,0.0000030206793,0.0000038395883,8.2118993e-7,0.00013676069],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988918,0.0003187424,0.0001740218,0.00012698094,0.00042968613,0.000058926005],"domain_scores_gemma":[0.99794513,0.0011504699,0.00029452264,0.000044913817,0.00045869735,0.00010614663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023280913,0.000703614,0.0017057259,0.0022562246,0.00037872887,0.0019862272,0.0010787648,0.001977728,0.0029887692],"category_scores_gemma":[0.00285764,0.0002775701,0.0006974951,0.004314063,0.0010826282,0.0030314212,0.0007513224,0.0032534872,0.0012730325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097834025,0.00005511284,0.0004022185,0.023521395,0.000109553555,0.00026416068,0.00013180534,0.00025581804,0.00040060337,0.0072652027,0.033128034,0.93436825],"study_design_scores_gemma":[0.00005861493,0.00014198193,0.0016300485,0.017193042,0.0001997258,0.002028566,0.00031752666,0.00016460282,0.0001734222,0.0043520117,0.9737128,0.000027529806],"about_ca_topic_score_codex":0.0019989202,"about_ca_topic_score_gemma":0.002623056,"teacher_disagreement_score":0.0029887692,"about_ca_system_score_codex":0.0015245671,"about_ca_system_score_gemma":0.0024898956,"threshold_uncertainty_score":0.012312293},"labels":[],"label_agreement":null},{"id":"W9251540","doi":"10.18553/jmcp.2014.20.4.376","title":"Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events","year":2014,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface","funders":"Ministério da Saúde; Universidade de São Paulo","keywords":"Amiodarone; Medicine; Warfarin; Adverse effect; Odds ratio; CYP2C9; Maintenance dose; VKORC1; Internal medicine; Atrial fibrillation; Prothrombin time; Loading dose; Anesthesia; Gastroenterology","score_opus":0.08974925117754175,"score_gpt":0.3912391506886126,"score_spread":0.30148989951107086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W9251540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998278,0.00074894045,0.0001413717,0.000074061434,0.000012630363,0.000006243462,0.00010428104,0.0000068699446,0.00062766264],"genre_scores_gemma":[0.99966586,0.000094428986,0.000079411686,0.000026069183,0.000018664274,0.0000022077193,0.000054909797,0.0000030042597,0.000055386077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861884,0.0003978932,0.00022351586,0.00027245664,0.00034426973,0.00014290793],"domain_scores_gemma":[0.99221605,0.0025225913,0.0037375425,0.00046906722,0.00030489793,0.0007498239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069249317,0.00026373623,0.0005554916,0.00043752414,0.0002790462,0.0006431996,0.0002325471,0.0003976554,0.0026594084],"category_scores_gemma":[0.005899424,0.0001925801,0.0009182758,0.0007429478,0.00035350633,0.00030641453,0.00032937273,0.0005281387,0.0002898639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008722268,0.000054042575,0.99322116,0.000023475932,0.00024737598,0.00015606513,0.000037811402,0.00003069891,0.0013842323,0.00001186222,0.000065035354,0.0038960692],"study_design_scores_gemma":[0.000017091525,0.00026816156,0.9986142,0.0000050245776,0.00012239417,0.0005827078,0.000026199015,0.00011183925,0.00014766499,0.000017194454,0.0000853357,0.000002203799],"about_ca_topic_score_codex":0.0011921678,"about_ca_topic_score_gemma":0.0014322795,"teacher_disagreement_score":0.0026594084,"about_ca_system_score_codex":0.00022410268,"about_ca_system_score_gemma":0.00040824956,"threshold_uncertainty_score":0.008896589},"labels":[],"label_agreement":null}]}